These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35853358)
1. Prevalence of iatrogenic CNS inflammation at a tertiary neuroimmunology clinic. Kelly H; Johnson J; Jakubecz C; Serra A; Abboud H J Neuroimmunol; 2022 Sep; 370():577928. PubMed ID: 35853358 [TBL] [Abstract][Full Text] [Related]
2. Iatrogenic CNS demyelination in the era of modern biologics. Kumar N; Abboud H Mult Scler; 2019 Jul; 25(8):1079-1085. PubMed ID: 30767720 [TBL] [Abstract][Full Text] [Related]
3. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum. Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917 [TBL] [Abstract][Full Text] [Related]
4. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease. Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216 [TBL] [Abstract][Full Text] [Related]
5. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature. Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992 [TBL] [Abstract][Full Text] [Related]
7. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B; J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206 [TBL] [Abstract][Full Text] [Related]
8. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese. Chan KH; Lee R; Lee JC; Tse AC; Pang SY; Lau GK; Teo KC; Ho PW J Neuroimmunol; 2013 Sep; 262(1-2):100-5. PubMed ID: 23838529 [TBL] [Abstract][Full Text] [Related]
9. Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis. Oliveira LM; Apóstolos-Pereira SL; Pitombeira MS; Bruel Torretta PH; Callegaro D; Sato DK Mult Scler; 2019 Dec; 25(14):1907-1914. PubMed ID: 30417715 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): A case-series and review. Elsbernd PM; Hoffman WR; Carter JL; Wingerchuk DM Mult Scler Relat Disord; 2021 Feb; 48():102696. PubMed ID: 33360264 [TBL] [Abstract][Full Text] [Related]
11. Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review. Lin TY; Chien C; Lu A; Paul F; Zimmermann HG Expert Rev Neurother; 2021 Oct; 21(10):1101-1123. PubMed ID: 34551653 [TBL] [Abstract][Full Text] [Related]
12. Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort. Dauby S; Dive D; Lutteri L; Andris C; Hansen I; Maquet P; Lommers E Acta Neurol Belg; 2022 Feb; 122(1):135-144. PubMed ID: 34097296 [TBL] [Abstract][Full Text] [Related]
13. A comparison between subjective and objective measurements of spasticity in neuromyelitis optica spectrum disorder patients. Jinkarn N; Tisavipat N; Jitprapaikulsan J; Prayoonwiwat N; Rattanathamsakul N; Siritho S Mult Scler Relat Disord; 2022 Feb; 58():103517. PubMed ID: 35032877 [TBL] [Abstract][Full Text] [Related]
14. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome. Jarius S; Kleiter I; Ruprecht K; Asgari N; Pitarokoili K; Borisow N; Hümmert MW; Trebst C; Pache F; Winkelmann A; Beume LA; Ringelstein M; Stich O; Aktas O; Korporal-Kuhnke M; Schwarz A; Lukas C; Haas J; Fechner K; Buttmann M; Bellmann-Strobl J; Zimmermann H; Brandt AU; Franciotta D; Schanda K; Paul F; Reindl M; Wildemann B; J Neuroinflammation; 2016 Nov; 13(1):281. PubMed ID: 27802825 [TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders]. Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501 [TBL] [Abstract][Full Text] [Related]
16. Treatment of Neuromyelitis Optica Spectrum Disorders. Chan KH; Lee CY Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445343 [TBL] [Abstract][Full Text] [Related]
17. Neuromyelitis Optica (Devic's Syndrome): an Appraisal. Crout TM; Parks LP; Majithia V Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111 [TBL] [Abstract][Full Text] [Related]
18. Clinical and paraclinical profile of neuromyelitis optic spectrum disorder in a peruvian cohort. Castro-Suarez S; Guevara-Silva E; Osorio-Marcatinco V; Alvarez-Toledo K; Meza-Vega M; Caparó-Zamalloa C Mult Scler Relat Disord; 2022 Aug; 64():103919. PubMed ID: 35691236 [TBL] [Abstract][Full Text] [Related]
19. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M; J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675 [TBL] [Abstract][Full Text] [Related]
20. Encephalitis Induced by Immune Checkpoint Inhibitors: A Systematic Review. Velasco R; Villagrán M; Jové M; Simó M; Vilariño N; Alemany M; Palmero R; Martínez-Villacampa MM; Nadal E; Bruna J JAMA Neurol; 2021 Jul; 78(7):864-873. PubMed ID: 33720308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]